TG Therapeutics has raised its 2026 revenue guidance to $875-900 million, prompting Goldman Sachs to increase its price target to $39. The company is also focusing on expanding awareness and clinical ...
极搜 TG必备的搜索引擎，极搜JISOU帮你精准找到，想要的群组、频道、音乐 、视频 搜索机器人 极搜 TG必备的搜索引擎，极搜JISOU帮你精准找到，想要的群组、频道、音乐 、视频 搜索机器人 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results